Oral selenium supplementation study for selenium-deficiency patient with intestinal failure

Terui Keita0 个研究点目标入组 3 人开始时间: 2022年9月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with intestinal failure (short bowel syndrome, Allied disorders of Hirschsprung's disease, etc.) who received home parenteral nutrition or enteral nutrition.
•2) Patients with selenium dificiency (seleum under the threshold) at the time of screening test.
•3) Male or female patients aged 18-79 years at informed consent
•4) Patients whose enteral nutrition is expected to remain unchanged after study drug administration.
•5) Participants have signed informed consent forms.

•1) Patients who changed their nutritional method within 4 weeks prior to the administration.
•2) Patients who have taken the intravenous selenium products or the foods intended to supplement for selenium with in 4 weeks prior to the administration.
•3) Patients with hypersensitivity to selenium or other constituents
•4) Patients who have been or are currently undergoing treatment for arrhythmia
•5) Patients with renal dysfunction (creatinine clearance < 30 mL/min or eGFR < 30 mL/min/1.73 m2)
•6) Patients who are pregnant, possibly pregnant, within 28 days postpartum, or lactating.
•7) Patients who are judged to be unsuitable for the safe conduct of this study.

发起方

Terui Keita